Free tool
FAERS Monitor: Oxygen, Usp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205862 or its brand name (Oxygen, Usp, Oxygen). Reports on generic versions are filed under their own applications.
Reports
50,896
Serious
33,884
67% of reports
Hospitalization
21,622
Death reported
7,315
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea10,168
- cough5,446
- headache5,135
- diarrhoea4,547
- fatigue4,295
- nausea4,124
- pneumonia4,002
- dizziness3,637
- oxygen saturation decreased3,200
- death2,668
- hypotension2,430
- asthenia2,418
- malaise2,412
- off label use2,306
- weight decreased2,192
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 347 |
| 2005 | 353 |
| 2006 | 446 |
| 2007 | 487 |
| 2008 | 603 |
| 2009 | 735 |
| 2010 | 984 |
| 2011 | 1,098 |
| 2012 | 1,238 |
| 2013 | 1,420 |
| 2014 | 1,794 |
| 2015 | 2,038 |
| 2016 | 2,549 |
| 2017 | 2,251 |
| 2018 | 2,528 |
| 2019 | 2,119 |
| 2020 | 2,680 |
| 2021 | 2,011 |
| 2022 | 1,876 |
| 2023 | 3,527 |
| 2024 | 6,661 |
| 2025 | 7,564 |
| 2026 | 5,585 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,263 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| oxygen saturation decreasedSignal | 3,200 | 24.9 | 24.0 | 69,363 |
| coughSignal | 5,446 | 8.2 | 8.0 | 34,020 |
| dyspnoeaSignal | 10,168 | 7.5 | 7.4 | 58,205 |
| pneumoniaSignal | 4,002 | 5.2 | 5.0 | 13,458 |
| hypotensionSignal | 2,430 | 5.1 | 4.9 | 7,880 |
| headacheSignal | 5,135 | 3.4 | 3.3 | 8,912 |
| weight decreasedSignal | 2,192 | 3.3 | 3.1 | 3,456 |
| dizzinessSignal | 3,637 | 3.0 | 2.9 | 5,022 |
| diarrhoeaSignal | 4,547 | 2.9 | 2.8 | 5,897 |
| astheniaSignal | 2,418 | 2.7 | 2.6 | 2,550 |
| fatigueSignal | 4,295 | 2.3 | 2.2 | 3,211 |
| malaiseSignal | 2,412 | 2.3 | 2.2 | 1,759 |
| nauseaSignal | 4,124 | 2.2 | 2.1 | 2,652 |
| death | 2,668 | 1.3 | 1.2 | 170 |
| off label use | 2,306 | 1.1 | 1.0 | 17 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.